Related Experiment Video
Updated: Jun 30, 2025

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Published on: April 27, 2018
State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells
Anna Terrazzan1,2, Riccardo Vanini1, Pietro Ancona1
1Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Abstract:
Over recent years, the investigation of transposable elements (TEs) has granted researchers a deeper comprehension of their characteristics and functions, particularly regarding their significance in the mechanisms contributing to cancer development. This manuscript focuses on prostate carcinoma cell lines and offers a comprehensive review intended to scrutinize the associations and interactions between TEs and genes, as well as their response to treatment using various chemical drugs, emphasizing their involvement in cancer progression. We assembled a compendium of articles retrieved from the PubMed database to construct networks demonstrating correlations with genes and pharmaceuticals. In doing so, we linked the transposition of certain TE types to the expression of specific transcripts directly implicated in carcinogenesis. Additionally, we underline that treatment employing different drugs revealed unique patterns of TE reactivation. Our hypothesis gathers the current understanding and guides research toward evidence-based investigations, emphasizing the association between antiviral drugs, chemotherapy, and the reduced expression of TEs in patients affected by prostate cancer.
Insights
Transposable elements (TEs) are implicated in prostate cancer progression. Research suggests certain antiviral drugs and chemotherapy may reduce TEs, offering new therapeutic avenues.
Area of Science:
- Genomics
- Cancer Biology
- Pharmacology
Background:
- Transposable elements (TEs) are increasingly recognized for their role in cancer development.
- Their specific functions and interactions with genes in prostate cancer remain an active area of research.
Purpose of the Study:
- To review the association between transposable elements (TEs) and genes in prostate cancer.
- To examine the impact of various drug treatments on TE activity and expression in prostate cancer.
- To explore the potential of targeting TEs in prostate cancer therapy.
Main Methods:
- Literature review of articles from the PubMed database.
- Construction of gene-TE and drug-TE interaction networks.
- Analysis of TE expression patterns in response to different chemical drugs.
Main Results:
- Specific TE types were linked to the expression of transcripts involved in carcinogenesis.
- Different drug treatments exhibited unique patterns of TE reactivation.
- Evidence suggests a correlation between antiviral drugs, chemotherapy, and reduced TE expression in prostate cancer patients.
Conclusions:
- Transposable elements play a significant role in prostate cancer progression and gene expression.
- Drug treatments can modulate TE activity, with potential implications for cancer therapy.
- Antiviral drugs and chemotherapy may represent a strategy to reduce TEs in prostate cancer.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Non-LTR Retrotransposons
Abnormal Proliferation